Methylation of p16 CpG islands associated with malignant transformation of gastric dysplasia in a population-based study

Clinical Cancer Research

Volumn 10, Issue 15, 2004, Pages 5087-5093

  Sun, Yu ^a   Deng, Dajun ^a   You, Wei Cheng ^a   Bai, Hua ^a   Zhang, Lian ^a   Zhou, Jing ^a   Shen, Lin ^a   Ma, Jun Ling ^a   Xie, Yu Quan ^a   Li, Ji You ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; PROTEIN P16; TUMOR MARKER;

ADULT; ARTICLE; CANCER SCREENING; CHINA; CPG ISLAND; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DISEASE COURSE; DNA DETERMINATION; DNA METHYLATION; DNA SEQUENCE; DYSPLASIA; FEMALE; FOLLOW UP; GASTROSCOPY; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SEQUENCE ANALYSIS; STOMACH BIOPSY; STOMACH CARCINOGENESIS; STOMACH DISEASE;

ADULT; BASE SEQUENCE; BIOPSY; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA; DNA METHYLATION; FEMALE; GASTRIC MUCOSA; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RISK; SEQUENCE ANALYSIS, DNA; STOMACH DISEASES; SULFITES; TIME FACTORS;

EID: 4143063626     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-03-0622     Document Type: Article

References (37)

1. You WC, Li JY, Blot WJ, et al. Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int J Cancer 1999;83:615-9.
2. Rugge M, Cassaro M, Di Mario F, et al. Interdisciplinary Group on Gastric Epithelial Dysplasia (IGGED). The long term outcome of gastric epithelial neoplasia. Gut 2003;52:1111-6.
3. Rugge M, Correa P, Dixon MF, et al. Gastric dysplasia: the Padova International Classification. Am J Surg Pathol 2000;24:167-76.
4. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond) 1993;366:704-7.
5. Cairns P, Mao L, Merlo A, et al. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science (Wash DC) 1994;265:415-6.
6. Merlo A, Herman JG, Mao L, et al. 5′CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancer. Nat Med 1995;1:686-92.
7. Herman JG, Merlo A, Mao L, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995;55:4525-30.
8. Gonzales-Zulueta M, Bender CM, Yang AS, et al. Methylation of the 5′CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 1995;55:4531-5.
9. Wu MS, Lin YW, Sheu JC, et al. Intragenic homozygous deletions of MTS1 gene in gastric cancer in Taiwan. Jpn J Cancer Res 1996;87: 1052-5.
10. Takaoka AS, Kakiuchi H, Itoh F, et al. Infrequent alterations of the p16 (MTS-1) gene in human gastric cancer. Tumour Biol 1997;18: 95-103.
11. Gunther T, Schneider-Stock R, Pross M, et al. Alteration of p16/MTS1-tumor suppressor gene in gastric cancer. Pathol Res Pract 1998; 194:809-13.
12. Lee YY, Kang SH, Seo JY, et al. Alterations of p16INK4A and p15INK4B genes in GC. Cancer (Phila) 1997;80:1889-96.
13. Suzuki H, Itoh F, Toyota M, et al. Distinct methylation pattern and microsatellite instability in sporadic gastric cancer. Int J Cancer 1999; 83:309-13.
14. Toyota M, Ahuja N, Suzuki H, et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 1999;59:5438-42.
15. Shim YH, Kang GH, Ro JY. Correlation of p16 hypermethylation with p16 protein loss in sporadic gastric carcinomas. Lab Investig 2000;80:689-95.
16. Kang GH, Shim YH, Jung HY, et al. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 2001;61:2847-51.
17. Bai H, Gu LK, Zhou J, Deng DJ. p16 hypermethylation during gastric carcinogenesis of Wistar rats by N-methyl-N′-nitro-N-nitrosoguanidine. Mutat Res 2003;535:73-8.
18. You WC, Blot WJ, Li JY, et al. Precancerous gastric lesions in a population at high risk of stomach cancer. Cancer Res 1993;53:1317-21.
19. You WC, Zhao L, Chang YS, Blot WJ, Fraumeni JF. Progression of precancerous gastric lesions. Lancet 1995;345:866.
20. You WC, Zhang L, Gail MH, et al. Gastric dysplasia and gastric cancer: helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst (Bethesda) 2000;92:1607-12.
21. Chinese Association of Gastric Cancer. Classification and diagnostic criteria for the histologic gastric and duodenal biopsy specimens. Liaoning, China: Liaoning Publishing House; 1981.
22. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin Sb. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821-6.
23. Paz MF, Fraga MF, Avila S, et al. A systematic profile of DNA methylation in human cancer cell lines. Cancer Res 2003;63:1114-21.
24. Xiao W, Oefner PJ. Denaturing high-performance liquid chromatography: a review. Human Mutat 2001;17:439-74.
25. Deng D, Deng G, Smith MF, et al. Simultaneous detection of CpG methylation and single nucleotide polymorphism (SNP) by denaturing high performance liquid chromatography (DHPLC). Nucleic Acids Res 2002;30:e13.
26. Deng D, El-Rifai W, Ji J, et al. Hypermethylation of metallothionein-3 CpG island in gastric carcinoma. Carcinogenesis (Lond) 2002; 24:25-9.
27. Virmani AK, Muller C, Rathi A, et al. Aberrant methylation during cervical carcinogenesis. Clin Cancer Res 2001;7:584-9.
28. Klump B, Hsieh CJ, Holzmann K, Gregor M, Porschen R. Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus. Gastroenterology 1998;115:1381-6.
29. Nie Y, Liao J, Zhao X, et al. Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma. Carcinogenesis (Lond) 2002;23:1713-20.
30. Chyczewski L, Niklinska W, Naumnik W, Chyczewska E, Niklinski J. P16INK4a point mutations and promoter hypermethylation in bronchial preneoplastic lesions. Folia Histochem Cytobiol 2001;39S2: 33-5.
31. ARF in patients with severe oral epithelial dysplasia. Cancer Res 2002;62:5295-300.
32. Lamy A, Sesboue R, Bourguignon J, et al. Aberrant methylation of the CDKN2a/p16INK4a gene promoter region in preinvasive bronchial lesions: a prospective study in high-risk patients without invasive cancer. Int J Cancer 2002;100:189-93.
33. Herman JG, Esteller M. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 2002;196:1-7.
34. INK4b gene in myelodysplastic syndromes is frequent and acquired during disease progression. Blood 1998;91:2985-90.
35. Uchida T, Kinoshita T, Nagai H, et al. Hypermethylation of the p15INK4B gene in myelodysplastic syndromes. Blood 1997;90:1403-9.
36. Miyakura Y, Sugano K, Konishi F, et al. Extensive methylation of hMLH1 promoter region predominates in proximal colon cancer with microsatellite instability. Gastroenterology 2001;121:1300-9.
37. Paulsen M, Ferguson-Smith AC. DNA methylation in genomic imprinting, development, and disease. J Pathol 2001;195:97-110.